Journal Information
Vol. 149. Issue 6.
Pages 270 (September 2017)
Share
Download PDF
More article options
Vol. 149. Issue 6.
Pages 270 (September 2017)
Letter to the Editor
Differences between agalsidase α and agalsidase β in the treatment of Fabry disease
Diferencias entre agalsidasa α y agalsidasa β en el tratamiento de la enfermedad de Fabry
Visits
10
a Errores Congénitos del Metabolismo en Pacientes Adultos, Unidad de Enfermedades Minoritarias, Hospital Vall d’Hebron, Barcelona, Spain
b Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Salamanca, Salamanca, Spain
c Servicio de Medicina Interna, Hospital Central de la Cruz Roja, Madrid, Spain
Related content
Med Clin. 2017;149:271-210.1016/j.medcle.2017.08.012
Alberto Ortiz, Maria Dolores Sanchez-Niño
Med Clin. 2017;149:287-9210.1016/j.medcle.2017.08.020
Pablo Romero-Morelos, Arizbett Uribe-Jiménez, Cindy Bandala, Albros Poot-Vélez, Nora Ornelas-Corral, Miriam Rodríguez-Esquivel, Mariana Valdespino-Zavala, Keiko Taniguchi, Daniel Marrero-Rodríguez, Ricardo López-Romero, Mauricio Salcedo
This item has received
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail